Effects of MAPK inhibitors on CCR4-mediated chemotaxis against thymus and activation-regulated chemokine (TARC/CCL17) [5]

Journal of Dermatological Science

Volumn 36, Issue 3, 2004, Pages 186-188

  Moroi, Yoichi ^a   Yu, Bin ^a   Urabe, Kazunori ^a   Koga, Tetsuya ^a   Nakahara, Takeshi ^a   Dainichi, Teruki ^a   Uchi, Hiroshi ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHEMOKINE RECEPTOR CCR4; CX 659S; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SD 282; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL LINE; CELL MIGRATION; CELL VIABILITY; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; GRANULOCYTE; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

CHEMOKINES, CC; CHEMOTAXIS; ENZYME INHIBITORS; HUMANS; MAP KINASE SIGNALING SYSTEM; RECEPTORS, CHEMOKINE;

EID: 8444240162     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2004.08.013     Document Type: Letter

References (10)

1. J.J. Campbell, G. Haraldsen, J. Pan, J. Rottman, S. Qin, and P. Ponath The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells Nature 400 1999 776 780
2. C.H. Kim, L. Rott, E.J. Kunkel, M.C. Genovese, D.P. Andrew, and L. Wu Rules of chemokine receptor association with T cell polarization in vivo J Clin Invest 108 2001 1331 1339
3. O. Yoshie, T. Imai, and H. Nomiyama Chemokines in immunity Adv Immunol 78 2001 57 110
4. T. Kakinuma, K. Nakamura, M. Wakugawa, H. Mitsui, Y. Tada, and H. Saeki Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity J Allergy Clin Immunol 107 2001 535 541
5. G.P. Downey, J.R. Butler, H. Tapper, L. Fialkow, A.R. Saltiel, and B.B. Rubin Importance of MEK in neutrophil microbicidal responsiveness J Immunol 160 1998 434 443
6. D. Xythalis, M.B. Frewin, and P.W. Gudewicz Inhibition of IL-8-mediated MAPK activation in human neutrophils by beta1 integrin ligands Inflammation 26 2002 83 88
7. R. Niwa, E. Shoji-Hosaka, M. Sakurada, T. Shinkawa, K. Uchida, and K. Nakamura Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma Cancer Res 64 2004 2127 2133
8. H. Uchi, T. Koga, K. Urabe, Y. Moroi, and M. Furue CX-659S, a diaminouracil derivative, indirectly inhibits the function of Langerhans cells by blocking the MEK1/2-Erk1/2 pathway in keratinocytes J Invest Dermatol 120 2003 983 989
9. N. Ashida, H. Arai, M. Yamasaki, and T. Kita Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis J Biol Chem 276 2001 16555 16560
10. S. Suttitanamongkol, and A.R. Gear ADP receptor antagonists inhibit platelet aggregation induced by the chemokines SDF-1, MDC and TARC FEBS Lett 490 2001 84 87